dr. lockhart on next steps for regorafenib and tas-102 in mcrc
Published 4 years ago • 115 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
7:54
regorafenib vs tas-102 salvage therapy
-
12:47
debate: salvage therapy for mcrc? regorafenib followed by tas-102
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
1:30
dr. lockhart on dual-immunotherapy strategies in crc
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
3:39
impact of tas-102 in metastatic colorectal cancer - video abstract id 113320
-
4:14
the use of regorafenib in clinical practice
-
1:18
dr. mehta on rationale for a phase ii trial of tas-102/ramucirumab in gastric/gej cancer
-
2:47
mcrc: sequencing with regorafenib or tas-102